Acute Immunological Effects of Exercise in Cancer Patients
NCT ID: NCT05656651
Last Updated: 2024-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE2
60 participants
INTERVENTIONAL
2022-12-19
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer patients
Single exercise intervention following a HIIT protocol, duration \~20 mins
High intensity interval exercise training
Endurance training adapted to age, resting heart rate
Healthy adults
Single exercise intervention following a HIIT protocol, duration \~20 mins
High intensity interval exercise training
Endurance training adapted to age, resting heart rate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High intensity interval exercise training
Endurance training adapted to age, resting heart rate
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing acute cancer treatment (chemotherapy)
* signed informed consent
Exclusion Criteria
* medical contraindication to HIIT on cycle ergometer
* chemotherapeutic treatment 48 h prior
* Hb \<8g/dl; platelets \< 20,000/ul.
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität Duisburg-Essen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miriam Götte
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miriam Götte, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Essen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Essen
Essen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Deppe I, Beller R, Kiehl F, Lazzari N, Bennstein SB, Reinhardt D, Dirksen U, Gotte M. The impact of a single HIIT intervention on the mobilization of NK cells and ILCs in adolescents and young adults (AYA) undergoing cancer treatment: an interventional controlled trial. BMC Cancer. 2025 Apr 14;25(1):689. doi: 10.1186/s12885-025-14058-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACTIVE
Identifier Type: -
Identifier Source: org_study_id